Retraction: Blocking TRPV1 in nucleus accumbens inhibits persistent morphine conditioned place preference expression in rats (PLoS ONE (2014) 9:8 (e104546) DOI: 10.1371/journal.pone.0104546);Blocking TRPV1 in nucleus accumbens inhibits persistent morphine conditioned place preference expression in rats

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Heng, Li Jun ^a,b   Huang, Bo ^a   Guo, Heng ^c   Ma, Lian Ting ^b   Yuan, Wei Xin ^a   Song, Jian ^b   Wang, Peng ^a,b   Xu, Guo Zheng ^b   Gao, Guo Dong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^c Military General Hospital of Chengdu PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAZEPINE; MORPHINE; VANILLOID RECEPTOR 1; CAPSAICIN; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONDITIONED PLACE PREFERENCE TEST; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; MALE; MORPHINE ADDICTION; MOTOR ACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PRESYNAPTIC MEMBRANE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; RECEPTOR UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; IMMUNOELECTRON MICROSCOPY; METABOLISM; SPATIAL BEHAVIOR; SPRAGUE DAWLEY RAT; WESTERN BLOTTING; WITHDRAWAL SYNDROME;

ANIMALS; BLOTTING, WESTERN; CAPSAICIN; CRAVING; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICROSCOPY, IMMUNOELECTRON; MORPHINE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SPATIAL BEHAVIOR; TRPV CATION CHANNELS;

EID: 84905908564     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0230396     Document Type: Erratum

References (48)

1. O'Brien CP (1997) A range of research-based pharmacotherapies for addiction. Science 278: 66-70.
2. Wu LJ, Sweet TB, Clapham DE (2010) International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev 62: 381-404.
3. Matta JA, Ahern GP (2011) TRPV1 and synaptic transmission. Curr Pharm Biotechnol 12: 95-101.
4. Ho KW, Ward NJ, Calkins DJ (2012) TRPV1: a stress response protein in the central nervous system. Am J Neurodegener Dis 1: 1-14.
5. Micale V, Cristino L, Tamburella A, Petrosino S, Leggio GM, et al. (2009) Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems. Neurobiol Dis 36: 70-80.
6. Roberts JC, Davis JB, Benham CD (2004) [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res 995: 176-183. (Pubitemid 37522018)
7. Tian YH, Lee SY, Kim HC, Jang CG (2010) Repeated methamphetamine treatment increases expression of TRPV1 mRNA in the frontal cortex but not in the striatum or hippocampus of mice. Neurosci Lett 472: 61-64.
8. Cristino L, de Petrocellis L, Pryce G, Baker D, Guglielmotti V, et al. (2006) Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 139: 1405-1415.
9. Nguyen TL, Nam YS, Lee SY, Kim HC, Jang CG (2010) Effects of capsazepine, a transient receptor potential vanilloid type 1 antagonist, on morphine-induced antinociception, tolerance, and dependence in mice. Br J Anaesth 105: 668-674.
10. Adamczyk P, Miszkiel J, McCreary AC, Filip M, Papp M, et al. (2012) The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats. Brain Res 1444: 45-54.
11. Badiani A, Belin D, Epstein D, Calu D, Shaham Y (2011) Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci 12: 685-700.
12. Grueter BA, Brasnjo G, Malenka RC (2010) Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat Neurosci 13: 1519-1525.
13. Musella A, De Chiara V, Rossi S, Prosperetti C, Bernardi G, et al. (2009) TRPV1 channels facilitate glutamate transmission in the striatum. Mol Cell Neurosci 40: 89-97.
14. Benninger F, Freund TF, Hajos N (2008) Control of excitatory synaptic transmission by capsaicin is unaltered in TRPV1 vanilloid receptor knockout mice. Neurochem Int 52: 89-94.
15. de Lago E, de Miguel R, Lastres-Becker I, Ramos JA, Fernandez-Ruiz J (2004) Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. Brain Res 1007: 152-159.
16. Marinelli S, Di Marzo V, Berretta N, Matias I, Maccarrone M, et al. (2003) Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J Neurosci 23: 3136-3144. (Pubitemid 36531955)
17. Marinelli S, Vaughan CW, Christie MJ, Connor M (2002) Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J Physiol 543: 531-540. (Pubitemid 35012207)
18. Mori F, Ribolsi M, Kusayanagi H, Monteleone F, Mantovani V, et al. (2012) TRPV1 channels regulate cortical excitability in humans. J Neurosci 32: 873-879.
19. Sasamura T, Sasaki M, Tohda C, Kuraishi Y (1998) Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus. Neuroreport 9: 2045-2048. (Pubitemid 28300564)
20. Xing J, Li J (2007) TRPV1 receptor mediates glutamatergic synaptic input to dorsolateral periaqueductal gray (dl-PAG) neurons. J Neurophysiol 97: 503-511. (Pubitemid 46143373)
21. Yokoyama T, Saito T, Ohbuchi T, Hashimoto H, Suzuki H, et al. (2010) TRPV1 gene deficiency attenuates miniature EPSC potentiation induced by mannitol and angiotensin II in supraoptic magnocellular neurons. J Neurosci 30: 876-884.
22. Wu X, Shi M, Wei C, Yang M, Liu Y, et al. (2012) Potentiation of synaptic strength and intrinsic excitability in the nucleus accumbens after 10 days of morphine withdrawal. J Neurosci Res 90: 1270-1283.
23. Ma YY, Chu NN, Guo CY, Han JS, Cui CL (2007) NR2B-containing NMDA receptor is required for morphine-but not stress-induced reinstatement. Exp Neurol 203: 309-319.
24. LaLumiere RT, Kalivas PW (2008) Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci 28: 3170-3177. (Pubitemid 351442289)
25. Bossert JM, Gray SM, Lu L, Shaham Y (2006) Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking. Neuropsychopharmacology 31: 2197-2209. (Pubitemid 44413197)
26. Marinelli S, Pascucci T, Bernardi G, Puglisi-Allegra S, Mercuri NB (2005) Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology 30: 864-870. (Pubitemid 40570902)
27. Esmaeili MH, Sahraei H, Ali-Beig H, Ardehari-Ghaleh M, Mohammadian Z, et al. (2012) Transient inactivation of the nucleus accumbens reduces both the expression and acquisition of morphine-induced conditioned place preference in rats. Pharmacol Biochem Behav 102: 249-256.
28. Siggins GR, Martin G, Roberto M, Nie Z, Madamba S, et al. (2003) Glutamatergic transmission in opiate and alcohol dependence. Ann N Y Acad Sci 1003: 196-211. (Pubitemid 38083057)
29. Gass JT, Olive MF (2008) Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 75: 218-265. (Pubitemid 350235390)
30. Alcantara AA, Lim HY, Floyd CE, Garces J, Mendenhall JM, et al. (2011) Cocaine- and morphine-induced synaptic plasticity in the nucleus accumbens. Synapse 65: 309-320.
31. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, et al. (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824. (Pubitemid 27462969)
32. Szallasi A, Blumberg PM (1999) Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159-212.
33. Toth A, Boczan J, Kedei N, Lizanecz E, Bagi Z, et al. (2005) Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res 135: 162-168. (Pubitemid 40602409)
34. Mezey E, Toth ZE, Cortright DN, Arzubi MK, Krause JE, et al. (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A 97: 3655-3660. (Pubitemid 30183358)
35. Jin YH, Bailey TW, Li BY, Schild JH, Andresen MC (2004) Purinergic and vanilloid receptor activation releases glutamate from separate cranial afferent terminals in nucleus tractus solitarius. J Neurosci 24: 4709-4717. (Pubitemid 38668194)
36. Li DP, Chen SR, Pan HL (2004) VR1 receptor activation induces glutamate release and postsynaptic firing in the paraventricular nucleus. J Neurophysiol 92: 1807-1816.
37. Yuan WX, Heng LJ, Ma J, Wang XQ, Qu LJ, et al. (2013) Increased expression of cannabinoid receptor 1 in the nucleus accumbens core in a rat model with morphine withdrawal. Brain Res 1531: 102-112.
38. Li YQ, Li FQ, Wang XY, Wu P, Zhao M, et al. (2008) Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. J Neurosci 28: 13248-13257.
39. Milekic MH, Brown SD, Castellini C, Alberini CM (2006) Persistent disruption of an established morphine conditioned place preference. J Neurosci 26: 3010-3020.
40. Shen H, Moussawi K, Zhou W, Toda S, Kalivas PW (2011) Heroin relapse requires long-term potentiation-like plasticity mediated by NMDA2b-containing receptors. Proc Natl Acad Sci U S A 108: 19407-19412.
41. Bajo M, Crawford EF, Roberto M, Madamba SG, Siggins GR (2006) Chronic morphine treatment alters expression of N-methyl-D-aspartate receptor subunits in the extended amygdala. J Neurosci Res 83: 532-537. (Pubitemid 43384846)
42. Koya E, Spijker S, Voorn P, Binnekade R, Schmidt ED, et al. (2006) Enhanced cortical and accumbal molecular reactivity associated with conditioned heroin, but not sucrose-seeking behaviour. J Neurochem 98: 905-915. (Pubitemid 44051290)
43. Kuntz KL, Patel KM, Grigson PS, Freeman WM, Vrana KE (2008) Heroin self-administration: II. CNS gene expression following withdrawal and cue-induced drug-seeking behavior. Pharmacol Biochem Behav 90: 349-356.
44. Aguiar DC, Terzian AL, Guimaraes FS, Moreira FA (2009) Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. Psychopharmacology (Berl) 205: 217-225.
45. Lee J, Di Marzo V, Brotchie JM (2006) A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats. Neuropharmacology 51: 557-565. (Pubitemid 44215961)
46. Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, et al. (2001) Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Eur J Pharmacol 420: 123-131. (Pubitemid 32537687)
47. Panlilio LV, Mazzola C, Medalie J, Hahn B, Justinova Z, et al. (2009) Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats. Psychopharmacology (Berl) 203: 529-538.
48. Tzavara ET, Li DL, Moutsimilli L, Bisogno T, Di Marzo V, et al. (2006) Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Biol Psychiatry 59: 508-515. (Pubitemid 43320538)